Mechanical thrombextraction in patient with acute ischemic stroke on background of oral anticoagulant therapy

V.О. Yarosh, V.V. Babenko, O.E. Svyrydiuk, O.J. Zharinov, O.A. Yepanchintseva, B.M. Todurov

References  

1. Albers G.W., Marks M.P., Kemp S. et al. DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging // New Engl. J. Med.– 2018.– Vol. 378.– P. 708–718. doi: 10.1056/NEJMoa1713973.
2. Bejot Y., Ben Salem D., Osseby G.V. et al. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006 // Neurology.– 2009.– Vol. 72.– P. 346–353. doi: 10.1212/01.wnl.0000341280.31919.bd.
3. Diener H.C., Connolly S.J., Ezekowitz M.D. et al. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial // Lancet Neurol.– 2010.– Vol. 9 (12).– P. 1157–1163. doi: 10.1016/S1474-4422(10)70274-X.
4. Easton J.D., Lopes R.D., Bahit M.C. et al. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial // Lancet Neurol.– 2012.– Vol. 11.– P. 503–511. doi: 10.1016/S1474-4422(12)70092-3.
5. Emberson J., Lees K.R., Lyden P. et al.; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials // Lancet.– 2014.– Vol. 384.– P. 1929–1935. doi: 10.1016/S0140-6736(14)60584-5.
6. Freedman B., Martinez C., Katholing A., Rietbrock S. Residual risk of stroke and death in anticoagulant‐treated patients with atrial fibrillation // JAMA Cardiol.– 2016.– Vol. 1.– P. 366–368. doi: 10.1001/jamacardio.2016.0393.
7. Gupta A.C., Schaefer P.W., Chaudhry Z.A. et al. Interobserver reliability of baseline noncontrast CT Alberta Stroke Program Early CT Score for intra-arterial stroke treatment selection // Am. J. Neuroradiol.– 2012.– Vol. 33 (6).– P. 1046–1049. doi: 10.3174/ajnr.A2942.
8. Hacke W., Kaste M., Bluhmki E. et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke // New Engl. J. Med.– 2008.– Vol. 359.– P. 1317–1329. doi: 10.1056/NEJMoa0804656.
9. Hankey G.J., Patel M.R., Stevens S.R. et al. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of ROCKET AF // Lancet Neurol.– 2012.– Vol. 11.– P. 315–322. doi: 10.1016/S1474-4422(12)70042-X.
10. L’Allinec V., Sibon I., Mazighi M. et al. MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists // Neurology.– 2020.– Vol. 94 (8).– P. e842–e850. doi: 10.1212/WNL.0000000000008873.
11. Mozaffarian D., Benjamin E.J., Go A.S. et al. Heart disease and stroke statistics —2015 update: a report from the American Heart Association // Circulation.– 2015.– Vol. 131.– P. e29–322. doi: 10.1161/CIR.0000000000000350.
12. Nogueira R.G., Jadhav A.P., Haussen D.C. et al.; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct // New Engl. J. Med.– 2018.– Vol. 378 (1).– P. 11–21. doi: 10.1056/NEJMoa1706442.
13. Powers W.J., Rabinstein A.A., Ackerson T. et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association // Stroke.– 2019.– Vol. 50.– P. e344–e418. doi: 10.1161/STR.0000000000000211. 
14. Rost N.S., Giugliano R.P., Ruff C.T. et al. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48) // Stroke.– 2016.– Vol. 47.– P. 2075–2082.
15. Seiffge D.J., Werring D.J., Paciaroni M. et al. Timing of anticoagulation after recent schaemic stroke in patients with atrial fibrillation // Lancet Neurol.– 2019.– Vol. 18.– P. 117–126. doi: 10.1161/STROKEAHA.116.013540. 
16. The top 10 causes of death: factsheet. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
17. Thomalla G., Simonsen C.Z., Boutitie F. et al; WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset // New Engl. J. Med.– 2018.– Vol. 379.– P. 611–622. doi: 10.1056/NEJMoa1804355.
18. Vranckx P., Valgimigli M., Heidbuchel H. The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation // Arrhythm. Electrophysiol. Rev.– 2018.– Vol. 7 (1).– P. 55–61. doi:10.15420/aer.2017.50.1.